HEADER OXIDOREDUCTASE 02-JUL-03 1PWL TITLE CRYSTAL STRUCTURE OF HUMAN ALDOSE REDUCTASE COMPLEXED WITH NADP AND TITLE 2 MINALRESTAT COMPND MOL_ID: 1; COMPND 2 MOLECULE: ALDOSE REDUCTASE; COMPND 3 CHAIN: A; COMPND 4 EC: 1.1.1.21; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET15B KEYWDS ALDOSE REDUCTASE, ATOMIC RESOLUTION, TERNARY COMPLEX, INHIBITOR KEYWDS 2 BINDING, OXIDOREDUCTASE EXPDTA X-RAY DIFFRACTION AUTHOR O.EL-KABBANI,C.DARMANIN,T.R.SCHNEIDER,I.HAZEMANN,F.RUIZ,M.OKA, AUTHOR 2 A.JOACHIMIAK,C.SCHULZE-BRIESE,T.TOMIZAKI,A.MITSCHLER,A.PODJARNY REVDAT 6 03-APR-24 1PWL 1 REMARK REVDAT 5 13-MAR-24 1PWL 1 REMARK REVDAT 4 11-OCT-17 1PWL 1 REMARK REVDAT 3 24-FEB-09 1PWL 1 VERSN REVDAT 2 22-JUN-04 1PWL 1 JRNL REVDAT 1 24-FEB-04 1PWL 0 JRNL AUTH O.EL-KABBANI,C.DARMANIN,T.R.SCHNEIDER,I.HAZEMANN,F.RUIZ, JRNL AUTH 2 M.OKA,A.JOACHIMIAK,C.SCHULZE-BRIESE,T.TOMIZAKI,A.MITSCHLER, JRNL AUTH 3 A.PODJARNY JRNL TITL ULTRAHIGH RESOLUTION DRUG DESIGN. II. ATOMIC RESOLUTION JRNL TITL 2 STRUCTURES OF HUMAN ALDOSE REDUCTASE HOLOENZYME COMPLEXED JRNL TITL 3 WITH FIDARESTAT AND MINALRESTAT: IMPLICATIONS FOR THE JRNL TITL 4 BINDING OF CYCLIC IMIDE INHIBITORS JRNL REF PROTEINS V. 55 805 2004 JRNL REFN ISSN 0887-3585 JRNL PMID 15146479 JRNL DOI 10.1002/PROT.20001 REMARK 2 REMARK 2 RESOLUTION. 1.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : SHELXL-97 REMARK 3 AUTHORS : G.M.SHELDRICK REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 10.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 92.7 REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (NO CUTOFF). REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.100 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.099 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.125 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 6391 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 115144 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F). REMARK 3 R VALUE (WORKING + TEST SET, F>4SIG(F)) : 0.096 REMARK 3 R VALUE (WORKING SET, F>4SIG(F)) : 0.096 REMARK 3 FREE R VALUE (F>4SIG(F)) : 0.121 REMARK 3 FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT (F>4SIG(F)) : 5905 REMARK 3 TOTAL NUMBER OF REFLECTIONS (F>4SIG(F)) : 109236 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2525 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 76 REMARK 3 SOLVENT ATOMS : 429 REMARK 3 REMARK 3 MODEL REFINEMENT. REMARK 3 OCCUPANCY SUM OF NON-HYDROGEN ATOMS : 2967.9 REMARK 3 OCCUPANCY SUM OF HYDROGEN ATOMS : 2390.2 REMARK 3 NUMBER OF DISCRETELY DISORDERED RESIDUES : 95 REMARK 3 NUMBER OF LEAST-SQUARES PARAMETERS : 28902 REMARK 3 NUMBER OF RESTRAINTS : 36371 REMARK 3 REMARK 3 RMS DEVIATIONS FROM RESTRAINT TARGET VALUES. REMARK 3 BOND LENGTHS (A) : 0.014 REMARK 3 ANGLE DISTANCES (A) : 0.032 REMARK 3 SIMILAR DISTANCES (NO TARGET VALUES) (A) : 0.000 REMARK 3 DISTANCES FROM RESTRAINT PLANES (A) : 0.028 REMARK 3 ZERO CHIRAL VOLUMES (A**3) : 0.095 REMARK 3 NON-ZERO CHIRAL VOLUMES (A**3) : 0.101 REMARK 3 ANTI-BUMPING DISTANCE RESTRAINTS (A) : 0.043 REMARK 3 RIGID-BOND ADP COMPONENTS (A**2) : 0.005 REMARK 3 SIMILAR ADP COMPONENTS (A**2) : 0.043 REMARK 3 APPROXIMATELY ISOTROPIC ADPS (A**2) : 0.095 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED: NULL REMARK 3 REMARK 3 STEREOCHEMISTRY TARGET VALUES : ENGH & HUBER REMARK 3 SPECIAL CASE: NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1PWL COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 08-JUL-03. REMARK 100 THE DEPOSITION ID IS D_1000019640. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 30-JUN-01 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 19-BM REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.900 REMARK 200 MONOCHROMATOR : MIRRORS REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : CUSTOM-MADE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 115145 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.100 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 92.6 REMARK 200 DATA REDUNDANCY : 3.630 REMARK 200 R MERGE (I) : 0.04100 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 25.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.61 REMARK 200 COMPLETENESS FOR SHELL (%) : 81.5 REMARK 200 DATA REDUNDANCY IN SHELL : 3.13 REMARK 200 R MERGE FOR SHELL (I) : 0.09210 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 11.75 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: X-PLOR REMARK 200 STARTING MODEL: ALDOSE REDUCTASE HOLOENZYME REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 24.90 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.64 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 6000, AMMONIUM CITRATE, PH 5, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 3 NE - CZ - NH1 ANGL. DEV. = 4.5 DEGREES REMARK 500 ARG A 3 NE - CZ - NH2 ANGL. DEV. = -3.6 DEGREES REMARK 500 ARG A 3 NE - CZ - NH2 ANGL. DEV. = -5.0 DEGREES REMARK 500 GLU A 64 CA - CB - CG ANGL. DEV. = 13.2 DEGREES REMARK 500 PHE A 121 CB - CG - CD1 ANGL. DEV. = 4.8 DEGREES REMARK 500 GLU A 193 OE1 - CD - OE2 ANGL. DEV. = -8.4 DEGREES REMARK 500 TYR A 209 CA - CB - CG ANGL. DEV. = 11.6 DEGREES REMARK 500 ARG A 217 NE - CZ - NH2 ANGL. DEV. = -3.3 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 21 4.22 81.37 REMARK 500 ASN A 50 11.98 -140.01 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BFI A 320 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAP A 318 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1PWM RELATED DB: PDB REMARK 900 THE SAME PROTEIN COMPLEXED WITH NADP AND FIDARESTAT DBREF 1PWL A 0 315 UNP P15121 ALDR_HUMAN 1 316 SEQRES 1 A 316 MET ALA SER ARG ILE LEU LEU ASN ASN GLY ALA LYS MET SEQRES 2 A 316 PRO ILE LEU GLY LEU GLY THR TRP LYS SER PRO PRO GLY SEQRES 3 A 316 GLN VAL THR GLU ALA VAL LYS VAL ALA ILE ASP VAL GLY SEQRES 4 A 316 TYR ARG HIS ILE ASP CYS ALA HIS VAL TYR GLN ASN GLU SEQRES 5 A 316 ASN GLU VAL GLY VAL ALA ILE GLN GLU LYS LEU ARG GLU SEQRES 6 A 316 GLN VAL VAL LYS ARG GLU GLU LEU PHE ILE VAL SER LYS SEQRES 7 A 316 LEU TRP CYS THR TYR HIS GLU LYS GLY LEU VAL LYS GLY SEQRES 8 A 316 ALA CYS GLN LYS THR LEU SER ASP LEU LYS LEU ASP TYR SEQRES 9 A 316 LEU ASP LEU TYR LEU ILE HIS TRP PRO THR GLY PHE LYS SEQRES 10 A 316 PRO GLY LYS GLU PHE PHE PRO LEU ASP GLU SER GLY ASN SEQRES 11 A 316 VAL VAL PRO SER ASP THR ASN ILE LEU ASP THR TRP ALA SEQRES 12 A 316 ALA MET GLU GLU LEU VAL ASP GLU GLY LEU VAL LYS ALA SEQRES 13 A 316 ILE GLY ILE SER ASN PHE ASN HIS LEU GLN VAL GLU MET SEQRES 14 A 316 ILE LEU ASN LYS PRO GLY LEU LYS TYR LYS PRO ALA VAL SEQRES 15 A 316 ASN GLN ILE GLU CYS HIS PRO TYR LEU THR GLN GLU LYS SEQRES 16 A 316 LEU ILE GLN TYR CYS GLN SER LYS GLY ILE VAL VAL THR SEQRES 17 A 316 ALA TYR SER PRO LEU GLY SER PRO ASP ARG PRO TRP ALA SEQRES 18 A 316 LYS PRO GLU ASP PRO SER LEU LEU GLU ASP PRO ARG ILE SEQRES 19 A 316 LYS ALA ILE ALA ALA LYS HIS ASN LYS THR THR ALA GLN SEQRES 20 A 316 VAL LEU ILE ARG PHE PRO MET GLN ARG ASN LEU VAL VAL SEQRES 21 A 316 ILE PRO LYS SER VAL THR PRO GLU ARG ILE ALA GLU ASN SEQRES 22 A 316 PHE LYS VAL PHE ASP PHE GLU LEU SER SER GLN ASP MET SEQRES 23 A 316 THR THR LEU LEU SER TYR ASN ARG ASN TRP ARG VAL CYS SEQRES 24 A 316 ALA LEU LEU SER CYS THR SER HIS LYS ASP TYR PRO PHE SEQRES 25 A 316 HIS GLU GLU PHE HET BFI A 320 28 HET NAP A 318 48 HETNAM BFI 2[4-BROMO-2-FLUOROPHENYL)METHYL]-6- HETNAM 2 BFI FLUOROSPIRO[ISOQUINOLINE-4-(1H),3'-PYRROLIDINE]-1,2', HETNAM 3 BFI 3,5'(2H)-TETRONE HETNAM NAP NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE HETSYN BFI MINALRESTAT HETSYN NAP 2'-MONOPHOSPHOADENOSINE 5'-DIPHOSPHORIBOSE FORMUL 2 BFI C19 H11 BR F2 N2 O4 FORMUL 3 NAP C21 H28 N7 O17 P3 FORMUL 4 HOH *429(H2 O) HELIX 1 1 PRO A 23 GLY A 38 1 16 HELIX 2 2 ALA A 45 GLN A 49 5 5 HELIX 3 3 ASN A 50 GLU A 64 1 15 HELIX 4 4 LYS A 68 LEU A 72 5 5 HELIX 5 5 TRP A 79 HIS A 83 5 5 HELIX 6 6 GLU A 84 GLY A 86 5 3 HELIX 7 7 LEU A 87 LYS A 100 1 14 HELIX 8 8 ASN A 136 GLU A 150 1 15 HELIX 9 9 ASN A 162 ASN A 171 1 10 HELIX 10 10 GLN A 192 LYS A 202 1 11 HELIX 11 11 SER A 226 GLU A 229 5 4 HELIX 12 12 ASP A 230 HIS A 240 1 11 HELIX 13 13 THR A 243 GLN A 254 1 12 HELIX 14 14 THR A 265 LYS A 274 1 10 HELIX 15 15 SER A 281 SER A 290 1 10 HELIX 16 16 LEU A 300 THR A 304 5 5 SHEET 1 A 2 ARG A 3 LEU A 5 0 SHEET 2 A 2 LYS A 11 PRO A 13 -1 O MET A 12 N ILE A 4 SHEET 1 B 8 LEU A 17 GLY A 18 0 SHEET 2 B 8 HIS A 41 ASP A 43 1 O ASP A 43 N LEU A 17 SHEET 3 B 8 PHE A 73 LEU A 78 1 O VAL A 75 N ILE A 42 SHEET 4 B 8 LEU A 106 ILE A 109 1 O LEU A 108 N LEU A 78 SHEET 5 B 8 ILE A 156 SER A 159 1 O GLY A 157 N TYR A 107 SHEET 6 B 8 VAL A 181 GLU A 185 1 O VAL A 181 N ILE A 158 SHEET 7 B 8 VAL A 205 TYR A 209 1 O THR A 207 N ILE A 184 SHEET 8 B 8 VAL A 258 VAL A 259 1 O VAL A 258 N ALA A 208 SITE 1 AC1 14 TRP A 20 VAL A 47 TYR A 48 TRP A 79 SITE 2 AC1 14 HIS A 110 TRP A 111 THR A 113 PHE A 122 SITE 3 AC1 14 TRP A 219 CYS A 298 ALA A 299 LEU A 300 SITE 4 AC1 14 NAP A 318 HOH A2323 SITE 1 AC2 36 GLY A 18 THR A 19 TRP A 20 LYS A 21 SITE 2 AC2 36 ASP A 43 TYR A 48 HIS A 110 SER A 159 SITE 3 AC2 36 ASN A 160 GLN A 183 TYR A 209 SER A 210 SITE 4 AC2 36 PRO A 211 LEU A 212 GLY A 213 SER A 214 SITE 5 AC2 36 PRO A 215 ASP A 216 LEU A 228 ALA A 245 SITE 6 AC2 36 ILE A 260 PRO A 261 LYS A 262 SER A 263 SITE 7 AC2 36 VAL A 264 THR A 265 ARG A 268 GLU A 271 SITE 8 AC2 36 ASN A 272 BFI A 320 HOH A2110 HOH A2132 SITE 9 AC2 36 HOH A2133 HOH A2285 HOH A2307 HOH A2382 CRYST1 40.019 47.128 47.367 75.71 67.48 76.75 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.024988 -0.005884 -0.009469 0.00000 SCALE2 0.000000 0.021799 -0.003918 0.00000 SCALE3 0.000000 0.000000 0.023221 0.00000 CONECT 2705 2707 2708 CONECT 2706 2709 2710 CONECT 2707 2705 2710 2711 CONECT 2708 2705 2709 2712 CONECT 2709 2706 2708 CONECT 2710 2706 2707 2713 CONECT 2711 2707 2719 2721 2732 CONECT 2712 2708 CONECT 2713 2710 2717 2718 CONECT 2714 2721 CONECT 2715 2720 2732 CONECT 2716 2720 CONECT 2717 2713 CONECT 2718 2713 2721 2722 CONECT 2719 2711 2720 CONECT 2720 2715 2716 2719 CONECT 2721 2711 2714 2718 CONECT 2722 2718 2723 CONECT 2723 2722 2725 2726 CONECT 2724 2727 2728 2730 CONECT 2725 2723 2728 CONECT 2726 2723 2727 2729 CONECT 2727 2724 2726 CONECT 2728 2724 2725 CONECT 2729 2726 CONECT 2730 2724 CONECT 2731 2732 CONECT 2732 2711 2715 2731 CONECT 2733 2734 2735 2736 2755 CONECT 2734 2733 CONECT 2735 2733 CONECT 2736 2733 2737 CONECT 2737 2736 2738 CONECT 2738 2737 2739 2740 CONECT 2739 2738 2744 CONECT 2740 2738 2741 2742 CONECT 2741 2740 CONECT 2742 2740 2743 2744 CONECT 2743 2742 2777 CONECT 2744 2739 2742 2745 CONECT 2745 2744 2746 2754 CONECT 2746 2745 2747 CONECT 2747 2746 2748 CONECT 2748 2747 2749 2754 CONECT 2749 2748 2750 2751 CONECT 2750 2749 CONECT 2751 2749 2752 CONECT 2752 2751 2753 CONECT 2753 2752 2754 CONECT 2754 2745 2748 2753 CONECT 2755 2733 2756 CONECT 2756 2755 2757 2758 2759 CONECT 2757 2756 CONECT 2758 2756 CONECT 2759 2756 2760 CONECT 2760 2759 2761 CONECT 2761 2760 2762 2763 CONECT 2762 2761 2767 CONECT 2763 2761 2764 2765 CONECT 2764 2763 CONECT 2765 2763 2766 2767 CONECT 2766 2765 CONECT 2767 2762 2765 2768 CONECT 2768 2767 2769 2776 CONECT 2769 2768 2770 CONECT 2770 2769 2771 2774 CONECT 2771 2770 2772 2773 CONECT 2772 2771 CONECT 2773 2771 CONECT 2774 2770 2775 CONECT 2775 2774 2776 CONECT 2776 2768 2775 CONECT 2777 2743 2778 2779 2780 CONECT 2778 2777 CONECT 2779 2777 CONECT 2780 2777 MASTER 221 0 2 16 10 0 13 6 3030 1 76 25 END